HAMI 3379 is a Selective CysLT2 Receptor Antagonist with Neuroprotective Effect
The cysteinyl leukotrienes (CysLTs) are inflammatory mediators closely associated with neuronal injury after brain ischemia through the activation of the CysLT1 receptor and the CysLT2 receptor. Specifically, CysLTs, namely leukotriene C4…